Cargando…

Peritoneal Metastases from Extraperitoneal Primary Tumors: Incidence, Treatment, and Survival from a Nationwide Database

The objective of this study was to assess the incidence, treatment, and survival of patients with synchronous peritoneal metastases (PM) from extraperitoneal primary tumors. A cohort was selected from the Netherlands Cancer Registry (NCR), in which all patients diagnosed with PM in 2017 and 2018 wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rijken, Anouk, Galanos, Laskarina J. K., Burger, Jacobus W. A., Nienhuijs, Simon W., van Erning, Felice N., de Hingh, Ignace H. J. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284768/ https://www.ncbi.nlm.nih.gov/pubmed/37359924 http://dx.doi.org/10.1007/s13193-022-01592-w

Ejemplares similares

Updated Incidence, Treatment and Survival of a Nationwide Cohort of Patients with Peritoneal Metastases of Unknown Origin
por: Rijken, Anouk, et al.
Publicado: (2022)

The impact of body weight on the development of peritoneal metastases in colorectal cancer patients: results from a nationwide cohort study
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023)

The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
por: Rijken, Anouk, et al.
Publicado: (2021)

The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study
por: Lurvink, Robin J., et al.
Publicado: (2022)

Synchronous peritoneal metastases from lung cancer: incidence, associated factors, treatment and survival: a Dutch population-based study
por: Lurvink, Robin J., et al.
Publicado: (2021)

Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study
por: Rijken, Anouk, et al.
Publicado: (2023)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
por: Simkens, Geert A, et al.
Publicado: (2017)

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Intra-Operative Radiotherapy for Patients with Locally Advanced or Locally Recurrent Rectal Cancer and Peritoneal Metastases
por: van de Vlasakker, Vincent C. J., et al.
Publicado: (2023)

Treatment Strategies and Prognosis of Patients With Synchronous or Metachronous Colorectal Peritoneal Metastases: A Population-Based Study
por: Bakkers, C., et al.
Publicado: (2021)

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC
por: Simkens, Geert A, et al.
Publicado: (2021)

ASO Author Reflections: Patient-Reported Outcomes of the CAIRO6 Phase II Trial
por: Bakkers, Checca, et al.
Publicado: (2023)

Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
por: Kranenburg, Onno, et al.
Publicado: (2021)

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases
por: Simkens, Geert A., et al.
Publicado: (2018)

Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)
por: Lurvink, Robin J., et al.
Publicado: (2021)

Comparison of the Peritoneal Cancer Index and Dutch region count as tools to stage patients with peritoneal metastases of colorectal cancer
por: Verheij, F. S., et al.
Publicado: (2020)

A population‐based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer
por: de Boer, Nadine L., et al.
Publicado: (2020)

Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands
por: Burg, Lara, et al.
Publicado: (2020)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

Extraperitoneal Placement of a Peritoneal Dialysis Catheter
por: Nakamura, Yasuna, et al.
Publicado: (2018)

DNA and RNA Alterations Associated with Colorectal Peritoneal Metastases: A Systematic Review
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC
por: Sluiter, Nina R., et al.
Publicado: (2018)

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
por: van't Erve, Iris, et al.
Publicado: (2021)

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial
por: Bakkers, C., et al.
Publicado: (2023)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Repetitive electrostatic pressurised intraperitoneal aerosol chemotherapy (ePIPAC) with oxaliplatin as a palliative monotherapy for isolated unresectable colorectal peritoneal metastases: protocol of a Dutch, multicentre, open-label, single-arm, phase II study (CRC-PIPAC)
por: Rovers, Koen P, et al.
Publicado: (2019)

Patient-reported outcomes (PROs) after total extraperitoneal hernia repair (TEP)
por: Mommers, E. H. H., et al.
Publicado: (2016)

Predictive Genetic Biomarkers for the Development of Peritoneal Metastases in Colorectal Cancer
por: Heuvelings, Danique J. I., et al.
Publicado: (2023)

Retroperitoneoscopic bilateral nephrectomy and extraperitoneal ureterocystoplasty in a child on peritoneal dialysis
por: Alam, Marianne, et al.
Publicado: (2020)

2022 Peritoneal Surface Oncology Group International Consensus on HIPEC Regimens for Peritoneal Malignancies: Colorectal Cancer
por: Hübner, Martin, et al.
Publicado: (2023)

The Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) versus Conventional Surgery on Patient-Reported Outcomes: A Comparative Cohort Study between the CAIRO6 Trial and the PROCORE Study
por: Bakkers, Checca, et al.
Publicado: (2023)

First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)
por: Lurvink, Robin J., et al.
Publicado: (2021)

Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial
por: de Boer, Nadine Leonie, et al.
Publicado: (2019)

Minilaparoscopic Technique for Inguinal Hernia Repair Combining Transabdominal Pre-Peritoneal and Totally Extraperitoneal Approaches
por: Carvalho, Gustavo L., et al.
Publicado: (2012)

Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review
por: Wintjens, Anne G. W. E., et al.
Publicado: (2022)

Second and third look laparoscopy in pT4 colon cancer patients for early detection of peritoneal metastases; the COLOPEC 2 randomized multicentre trial
por: Bastiaenen, Vivian P., et al.
Publicado: (2019)

Treating colorectal peritoneal metastases with an injectable cytostatic loaded supramolecular hydrogel in a rodent animal model
por: Wintjens, Anne G. W. E., et al.
Publicado: (2023)

Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy
por: Ubink, I., et al.
Publicado: (2019)

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience
por: Liu, Yang, et al.
Publicado: (2018)

Intraperitoneal Chemotherapy for Unresectable Peritoneal Surface Malignancies
por: Guchelaar, Niels A. D., et al.
Publicado: (2023)

Cytoreduction and HIPEC in The Netherlands: Nationwide Long-term Outcome Following the Dutch Protocol
por: Kuijpers, Anke M. J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pdmkp6hc6b9e2ucn56p9rdlasi